These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2249555)

  • 1. Morphological investigation of tumor growth and distribution of viable tumour areas in osteosarcomas after chemotherapy.
    Delling G; Pompesius-Kempa M; Welkerling H; Dreyer T; Maas R; Heise U; Winkler K
    Chir Organi Mov; 1990; 75(1 Suppl):45-7. PubMed ID: 2249555
    [No Abstract]   [Full Text] [Related]  

  • 2. Spontaneous necrosis in osteosarcoma.
    Springfield DS; Schakel ME; Spanier SS
    Clin Orthop Relat Res; 1991 Feb; (263):233-7. PubMed ID: 1993380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential of MRI in preoperative evaluation of chemotherapy-induced necrosis in osteosarcoma and Ewing's sarcoma.
    Maas R; Winkler K; Delling G; Heise U
    Chir Organi Mov; 1990; 75(1 Suppl):41-4. PubMed ID: 2249554
    [No Abstract]   [Full Text] [Related]  

  • 4. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
    Uhl M; Saueressig U; van Buiren M; Kontny U; Niemeyer C; Köhler G; Ilyasov K; Langer M
    Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous necrosis in osteosarcomas.
    von Hochstetter AR
    Chir Organi Mov; 1990; 75(1 Suppl):32-5. PubMed ID: 2249551
    [No Abstract]   [Full Text] [Related]  

  • 6. MRI and bone scan in osteosarcoma. Is preoperative assessment of tumor necrosis possible?
    Manfrini M; Spina V; Tarozzi C; Capanna R; Cerofolini E; Ruggieri P; Romagnoli R; Abbati A; Campanacci M
    Chir Organi Mov; 1990; 75(1 Suppl):38-40. PubMed ID: 2249553
    [No Abstract]   [Full Text] [Related]  

  • 7. Dynamic contrast enhanced magnetic resonance imaging subtraction in evaluating osteosarcoma response to chemotherapy.
    Torricelli P; Montanari N; Spina V; Manfrini M; Bertoni F; Saguatti G; Romagnoli R
    Radiol Med; 2001 Mar; 101(3):145-51. PubMed ID: 11402952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parametric imaging of 99mTc methylene diphosphonate biokinetics in osteosarcoma for preoperative evaluation of chemotherapy-induced necrosis.
    Knop J; Delling G; Heise U; Winkler K
    Chir Organi Mov; 1990; 75(1 Suppl):36-7. PubMed ID: 2249552
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy-induced changes in osteosarcoma after neoadjuvant chemotherapy (COSS 86 Therapy Study). Correlation between morphologic findings and clinical follow-up].
    Werner M; Fuchs N; Salzer-Kuntschik M; Winkler K; Delling G
    Pathologe; 1996 Jan; 17(1):35-43. PubMed ID: 8685094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An analysis of spontaneous and chemotherapy-associated changes in skeletal osteosarcomas.
    Misdorp W; Hart G; Delemarre JF; Voûte PA; van der Eijken JW
    J Pathol; 1988 Oct; 156(2):119-28. PubMed ID: 3199262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of necrosis caused by preoperative chemotherapy in 9 cases of classic central osteosarcoma].
    Carrillo G; Nappi O
    Pathologica; 1989; 81(1076):601-9. PubMed ID: 2635291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Margins, necrosis and local recurrence after conservative surgery in osteosarcoma.
    Picci P; Capanna R; Bacci G; Mercuri M; Biagini R; Ruggieri P; Ferraro A; De Cristofaro R; Ferruzzi A; Campanacci M
    Chir Organi Mov; 1990; 75(1 Suppl):82-5. PubMed ID: 2249566
    [No Abstract]   [Full Text] [Related]  

  • 13. [Morphological observations on osteosarcoma following regional perfusion of nitrogen mustard].
    Chen ML
    Zhonghua Wai Ke Za Zhi; 1982 May; 20(5):282-4. PubMed ID: 6957286
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro chemosensitivity assay for human osteosarcoma using tumor xenografts.
    Fujisaki T; Wada T; Takahashi M; Yamawaki S; Ishii S
    Clin Orthop Relat Res; 1995 Apr; (313):279-85. PubMed ID: 7641491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of the degree of morphological regression following chemotherapy in malignant bone tumors].
    Salzer-Kuntschik M; Brand G; Delling G
    Pathologe; 1983 May; 4(3):135-41. PubMed ID: 6576329
    [No Abstract]   [Full Text] [Related]  

  • 16. [Osteosarcoma: magnetic resonance imaging of the effects of preoperative chemotherapy].
    Spina V; Torricelli P; Manfrini M; Picci P; Romagnoli R
    Radiol Med; 1993 Jun; 85(6):725-32. PubMed ID: 8337428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation of the histological subtype of osteogenic sarcoma with the percentage of necrosis after initial chemotherapy].
    Liebhart M; Klepacka T; Michalak E
    Med Wieku Rozwoj; 2000; 4(2 Suppl 2):57-66. PubMed ID: 11178329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteosarcoma. Specimen management following primary chemotherapy.
    Raymond AK; Simms W; Ayala AG
    Hematol Oncol Clin North Am; 1995 Aug; 9(4):841-67. PubMed ID: 7490245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rationale of preoperative chemotherapy of osteosarcoma].
    Furuse K; Maeyama I; Morimoto K; Orito T; Okuno M
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1392-8. PubMed ID: 3473975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinico-morphologic characterization of lung metastases from osteogenic sarcoma during chemotherapy].
    Fedenko AN; Siniukov PA
    Arkh Patol; 1989; 51(3):22-8. PubMed ID: 2742512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.